Associations between lifetime classic psychedelic use and cardiometabolic diseases
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Associations between lifetime classic psychedelic use and cardiometabolic diseases
Authors
Keywords
-
Journal
Scientific Reports
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-13
DOI
10.1038/s41598-021-93787-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year
- (2021) Otto Simonsson et al. HYPERTENSION
- Associations between lifetime classic psychedelic use and markers of physical health
- (2021) Otto Simonsson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Psychedelics and health behaviour change
- (2021) Pedro J Teixeira et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The Current Status of Psychedelics in Psychiatry
- (2020) David Nutt et al. JAMA Psychiatry
- Psychedelics as a novel approach to treating autoimmune conditions
- (2020) Caitlin Thompson et al. IMMUNOLOGY LETTERS
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease
- (2019) Donna K. Arnett et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prevalence and epidemiological associates of novel psychedelic use in the United States adult population
- (2019) James D Sexton et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Chronic inflammation in the etiology of disease across the life span
- (2019) David Furman et al. NATURE MEDICINE
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Gregory A Roth et al. LANCET
- The relationships of classic psychedelic use with criminal behavior in the United States adult population
- (2017) Peter S Hendricks et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Type 2 diabetes
- (2017) Sudesna Chatterjee et al. LANCET
- Mental Health and Cardiovascular Disease
- (2016) Ashish Chaddha et al. AMERICAN JOURNAL OF MEDICINE
- The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization
- (2016) Ede Frecska et al. Frontiers in Pharmacology
- Interventions to Promote Physical Activity and Dietary Lifestyle Changes for Cardiovascular Risk Factor Reduction in Adults
- (2010) Nancy T. Artinian et al. CIRCULATION
- Drug harms in the UK: a multicriteria decision analysis
- (2010) David J Nutt et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started